Announcements
5 September 2025
Therapeutics | Important Update to Author Guidelines: New “Highlights” Section Required
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
Therapeutics (ISSN: 2813-9909) is committed to enhancing the visibility, accessibility, and impact of the research we publish. To help readers quickly identify and understand the core contributions of your work, we are introducing a new requirement for all article submissions.
Effective immediately, all new manuscripts are recommended to include a “Highlights” Section.
What are “Highlights”?
This is an optional Section in Therapeutics whose goal is to increase the discoverability and readability of the article via search engines and other scholars. Highlights should not be a copy of the abstract, but a simple text allowing the reader to quickly and simply find out what the article is about and what can be cited from it. Each of these parts should comprise up to two bullet points.
What are the main findings?
What are the implications of the main findings?
Please download the updated “Instructions for Authors” and template from the link below: https://www.mdpi.com/journal/therapeutics/instructions.
We appreciate your cooperation in implementing this new requirement, which will significantly benefit the broader scientific community. Thank you for choosing to publish with Therapeutics.